U.S. federal trademark · Serial No. 79087384 · Reg. No. 3922330
Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.